New CVS and Express Scripts Value Based Plans for Oncology

CVS and Express Scripts recently announced new plans to determine price and access to cancer drugs based on value. Learn more about these plans and others, such as Memorial Sloan Kettering’s Drug Abacus here. (Source: Tracey Walker, 4/3/16)

You might also be interested in:

Sloan Kettering Cancer Doc Steps Down After Failure to… September 17, 2018
Cancer Center’s Ties Raise Concerns December 6, 2018
eDossier System to Offer hēRo3 Model Integration November 8, 2018
Express Scripts Blocks 48 Drugs August 10, 2018
Cigna, Express Scripts Shareholders OK $67B Acquisition August 24, 2018
Express Scripts’ New Formulary Includes Lower List Prices November 14, 2018
JAMA Article Takes Look at Value-Based Drug Pricing June 6, 2018